These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3684769)

  • 1. [Various parameters of hemostasis in lung neoplasms].
    Kłoczko J; Wojtukiewicz M; Bielawiec M; Pilecka E
    Pol Tyg Lek; 1987 Jul; 42(29):884-5. PubMed ID: 3684769
    [No Abstract]   [Full Text] [Related]  

  • 2. [Content of soluble fibrin monomeric complexes, factor XIII and fibrin(ogen) degradation products in neonatal asphyxia].
    Suzuki S; Graeff H; Hafter R
    Arch Gynecol; 1979 Jul; 228(1-4):626-7. PubMed ID: 485520
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood coagulation studies in patients with acute leukemia before and after cytostatic chemotherapy].
    Bhaduri S; Rasche H; Köhle W; Dietrich M
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1142-4. PubMed ID: 611807
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fibrinolysis in patients with hypertension].
    Ena IaM; Didkovskaia LA
    Klin Med (Mosk); 1990 Dec; 68(12):18-20. PubMed ID: 2084328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on plasma F. XIII subunit a level and the detection of soluble fibrin monomer in collagen diseases].
    Okubo S; Suzuki H; Ishida T; Yasunaga K
    Rinsho Ketsueki; 1986 Aug; 27(8):1339-44. PubMed ID: 3795511
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of the hemostatic system in acute pneumonias at an early age].
    Shurygin DIa; Chireĭkin LV; Mednikov BL
    Sov Med; 1980; (8):20-2. PubMed ID: 7423231
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nonenzymatic fibrinolysis].
    Dzhurdzhev A; Atanasov K
    Vutr Boles; 1981; 20(3):18-22. PubMed ID: 6455858
    [No Abstract]   [Full Text] [Related]  

  • 8. [Products of degradation of fibrinogen in surgical patients].
    Golovastova GI; Guseĭnov ChS
    Lab Delo; 1975; (6):368-71. PubMed ID: 51128
    [No Abstract]   [Full Text] [Related]  

  • 9. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["Paracoagulation" phenomenon and fibrin- fibrinogen degradation products in acute poisoning with acetic acid].
    Kuznetsova AV
    Ter Arkh; 1977; 49(6):139-43. PubMed ID: 898038
    [No Abstract]   [Full Text] [Related]  

  • 11. [Approach of hematology. Abnormal findings of coagulation and fibrinolytic factors in DIC].
    Ikematsu S; Kato M; Kuroso K
    Rinsho Byori; 1984 Aug; 32(8):862-8. PubMed ID: 6502985
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fibrinase: its role in hemostasis].
    Baluda VP
    Lab Delo; 1968; 6():355-9. PubMed ID: 4184650
    [No Abstract]   [Full Text] [Related]  

  • 13. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
    Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disseminated intravascular coagulation syndrome (D.I.C.) and carcinoma of the prostate (author's transl)].
    Becopoulos T; Kranides A; Mandalaki-Yianitsiotis T; Louizou K; Panagiotopoulou E; Dimopoulos C
    J Urol (Paris); 1980; 86(6):467-70. PubMed ID: 6160184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in several blood coagulation parameters in the nephrotic syndrome].
    Gasparotto ML; Bertoli M; Bertaglia E; Vertolli U; Varchetta V; Favaro P; Rebeschini M; Di Lavoro D; Romagnoli GF
    Minerva Nefrol; 1981; 28(1):15-9. PubMed ID: 6793942
    [No Abstract]   [Full Text] [Related]  

  • 16. [Detection of fibrinolytic split products in patient collections with disordered hemostasis. I. In pathologically verified lung cancer. II. In thrombotic/embolic occurrences].
    Bube FW; Egenolf F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):447-54. PubMed ID: 6169607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selected hemostatic abnormalities associated with neoplastic disease.
    Ito R; Statland BE
    Clin Lab Med; 1982 Sep; 2(3):599-625. PubMed ID: 6814812
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: A new type of congenital dysfibrinogenemia (fibrinogen Tokyo) with defective stabilization of fibrin polymers.
    Samori T; Yatabe M; Ukita M; Fujimaki M; Fukutake K
    Thromb Diath Haemorrh; 1975 Sep; 34(1):329. PubMed ID: 1188745
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fibrinolysis and the level of fibrin stabilizing factor in patients with cavernous hemangiomas of the maxillofacial region].
    Andreenko GV; Kosorukova NIa
    Stomatologiia (Mosk); 1976; 55(1):31-4. PubMed ID: 1061380
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fibrinogen degradation products in pulmonary neoplastic diseases].
    Incoronato AM; Gennarelli E
    Arch Monaldi; 1975; 30(5-6):424-35. PubMed ID: 1234836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.